A review of smoking cessation in bipolar disorder: Implications for future research

Journal of Dual Diagnosis

Volumn 8, Issue 2, 2012, Pages 126-130

  George, Tony P ^a,b,c   Wu, Becky S ^a   Weinberger, Andrea H ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bipolar disorder; depression; drug safety; mania; review; smoking cessation; tobacco; varenicline

Indexed keywords

AMFEBUTAMONE; PLACEBO; VARENICLINE;

BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ASSESSMENT; DEPRESSION; HUMAN; PATIENT COMPLIANCE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT FAILURE;

EID: 84861413331     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504263.2012.671717     Document Type: Review

References (43)

1. Baethge, C., Tondo, L., Lepri, B., & Baldessarini, R. J. (2009). Coffee and cigarette use: Association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disorders, 11, 494-503. doi:10.1111/j.1399- 5618.2009.00727.x
2. BarChana, M., Levav, I., Lipschitz, I., Pugachova, I., Kohn, R., Weizman, A., & Grinshpoon, A. (2008). Enhanced cancer risk among patients with bipolar disorder. Journal of Affective Disorders, 108, 43-48. doi:10.1016/j.jad.2007.09.003 (Pubitemid 351444799)
3. Berk, M., Ng, F., Wang, W. V., Tohen, M., Lubman, D. I., Vieta, E., & Dodd, S. (2008). Going up in smoke: Tobacco smoking is associated with worse treatment outcomes in mania. Journal of Affective Disorders, 110, 126-134. doi:10.1016/j.jad.2008.01.018
4. Chuang, H., Mansell, C., & Patten, S. B. (2008). Lifestyle characteristics of psychiatric outpatients. Canadian Journal of Psychiatry, 53, 260-266. (Pubitemid 351838520)
5. Cassidy, F.,McEvoy, J. P., Yang, Y. K., & Wilson,W. H. (2002). Smoking and psychosis in patients with bipolar I disorder. Comprehensive Psychiatry, 43, 63-64. doi:10.1053/comp.2002.29847 (Pubitemid 34056277)
6. Corvin, A., O'Mahoney, E., O'Regan, M., Comerford, C., O'Connell, R., Craddock, N., & Gill, M. (2001). Cigarette smoking and psychotic symptoms in bipolar affective disorder. The British Journal of Psychiatry, 179, 35-38. doi:10.1192/bjp.179.1.35 (Pubitemid 32625994)
7. de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135-157. doi:10.1016/j.schres.2005.02.010 (Pubitemid 40812332)
8. Diaz, F., James, D., Botts, S., Maw, L., Susce, M. T., & de Leon, J. (2009). Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia and major depression. Bipolar Disorders, 11, 154-165. doi:10.1111/j.1399-5618.2009.00664.x
9. Dodd, S., Brnabic, A. J., Berk, L., Fitzgerald, P. B., de Castella, A. R., Filia, S., Berk,M. (2010). A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Comprehensive Psychiatry, 51, 504-509. doi:10.1016/j.comppsych.2009.12.001
10. Evins, A. E., Deckersbach, T., Cather, C., Freudenreich, O., Culhane, M. A., Henderson, D. C., Goff, D.C. (2005). Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. The Journal of Clinical Psychiatry, 66, 1184-1190. (Pubitemid 41442287)
11. Evins, A. E., Culhane, M. A., Alpert, J. E., Pava, J., Liese, B. S., Farabaugh, A., Fava, M. (2008). A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of Clinical Psychopharmacology, 28, 660-666. doi:10.1097/JCP.0b013e31818ad7d6
12. George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., Kosten, T. R. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53-61. doi:10.1016/S0006-3223 (02)01339-2 (Pubitemid 34655556)
13. George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., Kosten, T. R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. The American Journal of Psychiatry, 157, 1835-1842. doi:10.1176/appi.ajp.157.11.1835
14. George, T. P., Termine, A., Sacco, K. A., Seyal, A. A., Dudas, M. M., Allen, T. M., & Duncan, E. J. (2006). A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: Involvement of nicotinic receptor mechanisms. Schizophrenia Research, 87, 307-315. doi:10.1016/j.schres.2006.05.022 (Pubitemid 44462734)
15. George, T. P. (2007). Neurobiological links between nicotine addiction and schizophrenia. Journal of Dual Diagnosis, 3, 27-42. doi:10.1300/ J374v03n03 04 (Pubitemid 350171287)
16. George, T. P., Vessicchio, J. C., Sacco, K. A., Creeden, C. L., Dudas, M. M., Allen, T. A., Jatlow, P. I. (2008). A double-blind, randomized, placebocontrolled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry,63, 1092-1096. doi:10.1016/j.biopsych.2007.11.002
17. George, T. P. (2011). Nicotine and tobacco. In L. Goldman & A. I. Schafer (Eds.), Goldman's Cecil medicine (24th ed., pp. 142-146). New York, NY: Elsevier-Health Sciences Division.
18. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., Reeves, K. R. (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 296, 47-55. doi:10.1001/jama.296.1.47
19. Gonzalez-Pinto, A., Gutierrez, M., Ezcurra, J., Aizpuru, F., Mosquera, F., Lopez, P., & de Leon, J. (1998). Tobacco smoking and bipolar disorder. The Journal of Clinical Psychiatry, 59, 225-228. (Pubitemid 28274605)
20. Goldstein, B. I., Birmaher, B., Axelson, D. A., Goldstein, T. R., Esposito-Symthers, C., Stober, M. A., Keller, M. B. (2008). Significance of cigarette smoking among youths with bipolar disorder. The American Journal on Addictions, 17, 364-371. doi:10.1080/10550490802266151
21. Heffner, J. L., Delbello, M. P., Fleck, D. E., Anthenelli, R. M., & Strakowski,S. M. (2008). Cigarette smoking in the early course of bipolar illness: Association with ages-at-onset of alcohol and marijuana use. Bipolar Disorders, 10, 838-845. doi:10.1111/j.1399-5618.2008.00630.x
22. Heffner, J. L., Strawn, J. R., DelBello,M. P., Strakowski, S.M., & Anthenelli, R. M. (2011). The co-occurrence of cigarette smoking and bipolar disorder: Phenomenology and treatment considerations. Bipolar Disorders, 13, 439-453. doi:10.1111/j.1399-5618.2011.00943.x
23. Hitsman, B., Moss, T. G., Montoya, I. D., & George, T. P. (2009). Treatment of tobacco dependence inmental health and addictive disorders. Canadian Journal of Psychiatry, 54, 368-378.
24. Hong, L. E., Thaker, G. K., McMahon, R. P., Summerfelt, A., Rachbeisel, J., Fuller, R. L., Nye, A. (2011). Effects of moderatedose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 68, 1195-1206.doi:10.1001/archgenpsychiatry.2011.83
25. Jorenby, D. E.,Hays, J. T., Rigotti, N. A., Azoulay, S.,Watsky, E. J.,Williams, K. E., . . .Varenicline phase 3 Study Group. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 296, 56-63. doi:10.1001/jama.296.1.56
26. Kohen, I., & Kremen, N. (2007). Varenicline-induced manic episode in apatient with bipolar disorder. The American Journal of Psychiatry, 164, 1269-1270. doi:10.1176/appi.ajp.2007.07010173 (Pubitemid 47292424)
27. Lasser, K., Boyd, J. W., Woolhander, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A populationbased prevalence study. JAMA: The Journal of the American Medical Association, 284, 2606-2610. doi:10.1001/jama.284.20.2606
28. Law, C. W., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., Brooks, J. O. III, & McIntyre, R. S. (2009). Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder. Pharmacology, Biochemistry, and Behavior, 92, 12-16. doi:10.1016/j.pbb.2008.10.002
29. McClure, J. B., Swan, G. E., Catz, S. L., Jack, L., Javitz, H., McAfee, T., Zbikowski, S. M. (2010). Smoking outcome by psychiatric history after behavioural and varenicline treatment. Journal of Substance Abuse Treatment, 38, 394-402. doi:10.1016/j.jsat.2010.03.007
30. McFall, M., Saxon, A. J.,Malte, C. A., Chow, B., Bailey, S., Baker, D. G., CSP 519 Study Team. (2010). Integrating tobacco cessation into mental health care for posttraumatic stress disorder: A randomized controlled trial. JAMA: The Journal of the AmericanMedical Association, 304, 2485-2493. doi:10.1001/jama.2010.1769
31. Ostacher, M. J., Nierenberg, A. A., Perlis, R. H., Eidelman, P., Borreli, D. J., Tran, T. B., Sachs, G. S. (2006). The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. The Journal of Clinical Psychiatry, 67, 1907-1911. (Pubitemid 46048187)
32. Prochaska, J. J., Reyes, R. S., Schroder, S. A., Daniels, A. S., Doederlein, A., & Bergeson, B. (2011). An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disorders, 13, 466-473. doi:10.1111/j.1399-5618.2011. 00944.x
33. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA: The Journal of the American Medical Association, 264, 2511-2518.
34. Sacco, K. A., Termine, A., Seyal, A. A., Dudas, M. M., Vessicchio, J. C., Krishnan-Sarin, S., George, T. P. (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms. Archives of General Psychiatry, 62, 649-659. (Pubitemid 40973440)
35. Schaffer, A., Cairney, J., Cheung, A., Veldhuizen, S., & Levitt, A. (2006). Community survey of bipolar disorder in Canada: Lifetime prevalence and illness characteristics. Canadian Journal of Psychiatry, 51, 9-16. (Pubitemid 43234941)
36. Schroeder, S. A. (2009). A 51-year old woman with bipolar disorder who wants to quit smoking. JAMA: The Journal of the American Medical Association, 301, 522-531. doi:10.1001/jama.2008.982
37. Stapleton, J. A., Watson, L., Spirling, L. I., Smith, R., Milbrandt, A., Ratcliffe, M., & Sutherland, G. (2008). Varenicline in the routine treatment of tobacco dependence: A pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction, 103, 146-154. doi:10.1111/j.1360-0443.2007.02083.x (Pubitemid 350233424)
38. Waxmonsky, J. A., Thomas,M.R., Miklowitz, D. J.,Allen,M. H.,Wisniewski, S. R., Zhang, H., Fossey, M. D. (2005). Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systemic Treatment Enhancement Program (STEP-BD). General Hospital Psychiatry, 27, 321-328. (Pubitemid 41317047)
39. Weinberger, A. H., Vessicchio, J. C., Sacco, K. A., Creeden, C. L., Chengappa, K. N., & George, T. P. (2008). A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. Journal of Clinical Psychopharmacology, 28, 584-587. doi:10.1097/JCP.0b013e318184ba3c
40. Williams, J. M., Anthenelli, R. M., Morris, C., Tredow, J., Thompson, J. R., Yunis, C., & George, T. P. (in press). A double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline tartrate for smoking cessation in schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry.
41. Wing, V. C., Moss, T. G., Rabin, R. A., & George, T. P. (2012). Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls. Addictive Behaviors, 37, 67-72.
42. Wu, B. S., Weinberger, A. H., Mancuso, E., Wing, V. C., Haji-Khamneh, B., Levinson, A. J., & George, T. P. (2012). A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder. Journal of Dual Diagnosis, 8, 131-132. doi:10.1080/15504263.2012.671067
43. Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10 (12), 1691-1715.